Reaction Biology offers a variety of inhibitors of epigenetic events, such as DNA methylation and covalent modification of histones. Over the past few years, a significant increase in small molecule inhibitors chemically modulating enzymatic activity of Histone Methyltransferases (HMTs), Histone Demethylases (HDMs), and disrupting interactions of the BET family bromodomains have rapidly translated into clinical investigation.